|
The familiar characteristics of a tomato such as size,
flavour and colour are expressed by just 5% of the fruit - the rest being
water. Despite its broad appeal today, up until last century it was widely
feared as poisonous, just as its relatives belladonna and mandragora indeed
are.
In 1820 Robert Gibbon Johnson entered history for daring
to eat a tomato in front of a New Jersey Courthouse. Just 157 years later,
tomato has become the most consumed vegetable in the world.
The popularity of the tomato comes not only from its
flavour and freshness, but also because they are easy to conserve through
processing. You name it: ketchup, sun dried, tinned, powdered, pureed
or juiced - tomato processing has come a long way since jars of home preserve.
Such versatility coupled with a growing demand for the fresh fruits, has
pushed the development of tomato as a one of the main crops of the century.
Breeding which intensified in the US in the 1930's and Europe in the 1960's,
has been based on hybridisation. Such specialised development has taken
the crop away from the farmer and placed it in corporate hands.
Travelling North
Wild tomatoes are only found in the Andes, but no remains
indicate that it was ever cultivated in the region. One of these species
managed to reach Mexico where mesoamericans, who had already developed
sophisticated agriculture, proceeded to domesticate the newcomer. "Tomatl"
soon became familiar to their homes and markets. The wild tomato that
once travelled North still explains its story to those able to see it
as more than a weed of Southern Mexico.
Farmers turned tomato from cross-pollinating to self-pollinating.
As a result, the single species that emigrated North has developed a much
less diverse heritage than the wild relatives which stayed at home. Outside
the centre of origin where the cultivars cross-pollinate with the wild
relatives, all domesticated varieties are genetically quite homogeneous.
Despite this, an impressive array of variability has developed and today
Seed Savers networks maintain broad collections in their gardens. In the
US, people like Craig La Houllier and Carolyn Male, keep 800 varieties
in their collections. The United States department of Agriculture (USDA)
Plant Introduction Service has a list of 10,000 old varieties. These had
been developed all over the world, particularly in Europe, regardless
of previous poison fears.
Sadly, much of the diversity in tomato is gone forever.
A study by the Rural Advancement Foundation International (RAFI) in 1982,
found that 80% of commercial tomato varieties listed in 1903 by the USDA,
were no longer found in US seed banks, suggesting they had become extinct.
Tomato hybrids, today used for intensive production,
display a high degree of genetic uniformity. Both the practice of certified
seed production and the sharing of germplasm resources among breeders
have led to uniformity, convenient to the needs of both intensive industrial
production and tomato processors.
California, which now produces around 90% of the processing
tomato in the US, developed the first variety suitable for mechanical
harvesting. VF145 was the predominant processing variety for over 10 years.
Although it has been replaced by many new varieties, the genetic uniformity
of the crop remains high, because the newer varieties continue to share
a large proportion of their ancestry with VF145.
It is the centre of origin of the wild tomato where diversity
both within and between the nine species of the genus is compelling. It
includes for example, a salt-resistant species, which can grow just 5
metres from the sea. The contribution of such genetic diversity, to the
industrial growing of tomato is invaluable. At least 20 characteristics
for resistance from wild tomato plants have been introduced into horticultural
tomatoes. In fact, it is this diversity in wild tomatoes that has literally
made VF145, and industrial cultivation, possible.
Much of this has been due to the work of one of the undisputed
pioneers of industrial tomato breeding, Dr. C.M. Rick, of the University
of California, Davis. Since 1948, Rick has been one of the main collectors
of wild tomato species in their centre of origin. His efforts have led
to the creation of the C.M.Rick Tomato Genetic Resource Centre
(TGRC). Today, the TGRC holds 1010 accessions of wild species including
many recent acquisitions.
Table 1. The main
Ex-situ tomato collections in the world are controlled by the North.
| INSTITUTION, COUNTRY
|
% WORLD COLLECTION
|
| AVRDC ,Taiwan/International |
9
|
| National Seed Storage Laboratory, Fort
Collins, USA* |
8
|
| Horticulture Science Dept., N.Y. State
Agricultural. Exp. Station, USA |
6
|
| Campbell, Private company |
6
|
| Vavilov Research Institute, Russia |
4
|
| IPK, Germany |
4
|
| TOTAL |
37
|
* Includes sub-samples of the TGRC collection.
Source: GRAIN. Extracted from the State of the Worlds Plant Genetic
Resources for Food and Agriculture, FAO 1996 and FAO WIEWS on PGRFA, November
1996
Dr. Rick confirmed to GRAIN that the accessions in the
TGRC are available to all breeders who ask for them. The TGRC distributes
3000 to 4000 accessions each year, "We distribute them to both
the public and the private sector, in a proportion that is roughly fifty-fifty".
Rick went on to raise the familiar ghost of genetic erosion, "we
also serve petitions from the countries of origin of our accessions, because
the original populations have become extinct". Tomato provides
a prime case against the devastating pattern of genetic erosion, the reduction
of the South's biodiversity and control of genetic resources by the North.
Intensive development
Although tomato production in the South is larger than
in the North, tomato is clearly a commodity controlled by Northern countries.
In 1995, the North accounted for 72% of the world's US$2.8 billion tomato
exports market, and 94% of the imports. Not including the international
trade on added-value products such as tomato paste. The US and EU are
the main tomato markets. The high value of tomato on the international
market has seen continuous growth of tomato production (a 12% increase
between 1990 and 1995).
In most developing countries, tomato is a seasonal crop
integrated into complex local farming systems. It is highly valued for
the variety of ways it can be eaten, cooked, conserved, and selected for
its suitability to end uses. Its varied micro-nutrient content also plays
an important nutritional role.
| Distribution
of Tomato Production in 1995 |
However, when it comes to serving large distant markets,
and processing and retail industries that ask for particular, uniform
characteristics, other considerations come first. Virtually all formal
breeding on tomato has focused on increased yield which has led to industrialisation
of the crop. To those used to considering productivity in terms of commodity
yields, the results must look impressive. In 1996, world leader in tomato
intensification, the Netherlands, produced average yields of 466MT/Ha.
Compared with a European average of 38MT/Ha, and in China 27 MT/Ha.
High yields have been achieved through large scale use
of external inputs coupled with alteration of the growing environment,
particularly through use of greenhouses and in some cases doing away with
soil altogether. Such methods have inevitably stimulated the use of high
yield hybrids, which have been introduced to more extensive systems of
open field cultivation, such as those that utilise the Mediterranean climate.
Table 2. The top 10 tomato
producing countries account for 65% of world production.
| COUNTRY |
PRODUCTION
IN MT |
%
|
| CHINA |
12,832,440
|
15
|
| USA |
11,719,000
|
14
|
| TURKEY |
7,250,000
|
9
|
| ITALY |
5,155,598
|
6
|
| EGYPT |
5,034,197
|
6
|
| INDIA |
4,800,000
|
6
|
| SPAIN |
2,705,500
|
3
|
| BRAZIL |
2,700,197
|
3
|
| RUSSIAN
FED |
1,407,000
|
2
|
| CHILE |
1,264,244
|
1
|
| TOP TEN |
54,868,176
|
65
|
Source: GRAIN from AGROSTAT
Second on the breeders priority list is disease and insect
resistance. The essential role of Southern genetic resources here, have
not extended to including traits to decrease reliance on the use of chemicals.
Instead R&D priorities have adjusted particular characteristics of
the tomato making them bloom earlier and for longer or shorter
periods, thus influencing growth patterns. Or eliminating undesirable
traits such as removing the green collar around the insertion point that
may turn yellow instead of red, much to the horror of wholesalers.
The global commodity market for tomato has lead to intensive
R&D into delayed ripening. Harvesting, transport and storage all require
a strong fruit that will last the distance. Due to the ageing process
intrinsic to ripening, mature fruits are unsuitable, so a common technique
is to harvest fruits when they are still green. Ripening is then provoked
before sale using ethylene, a substance that plants normally produce to
initiate the process. However, when this technique is used in tomatoes
they end up flavourless and so less appealing to consumers. The challenge
to produce a fruit that could develop flavour on the plant and still be
strong enough to reach the end consumer resulted in the Daniela
hybrid. Developed in 1990 by Israeli and US breeders it became the first
"long shelf-life" tomato and takes twice the time to ripen.
Since then, long shelf-life hybrids have been developed with more appeal
to human senses.
Who harvests the benefits?
Tomato accounts for half of the world market for vegetable
seeds, estimated at US$1.6 billion. According to the international association
of seed producers FIS/ASSINSEL the tomato seed sector is currently dominated
by six companies: Empresas La Moderna, Limagrain, Novartis Seeds, Nunhems
Group, Sakata and Takii.
Many of the major breeders have profited handsomely from
relationships with the public sector. For example, French company Vilmorin,
today part of the Limagrain group, developed the first hybrid tomatoes
in 1947. The Institut National de la Recherche Agricole (INRA) developed
its first hybrids in 1962-63 and in 1989-1990, the INRA and the main French
seed groups, Clause-Limagrain, received a public grant to develop a network
of gene banks for the creation of tomato varieties.
| Dupont joins transgenic seed race
The biotech led integration between the seed
and agrochemical sectors moved yet another step ahead last August
when one of the last Mohicans, Pioneer Hi-Bred, entered into
a joint venture and research agreement with Du Pont by selling
20% of its shares for the bagatelle of US$1.7 billion. Now only
Limagrain remains as a large independent seed concern.
The agreement does include some safeguards
for Pioneer's independence. The company is to use Du Pont's
money to purchase an equivalent amount of shares from the market.
Du Pont has committed not to increase its participation in the
company in another 16 years, and the agreement does not provide
Du Pont access to Pioneer's insect and herbicide resistance
technologies nor seed distribution channels. However, it shows
that the company felt unable to compete with the huge amount
of money that Monsanto (who had offered to take the company
over) and its agrochemical rivals, are putting in their gambling
for agricultural biotech.
The joint venture both create one of the world's
largest private research and development collaborations and
consolidate the return of Du Pont to the seed and agricultural
biotech sectors in competition with the existing big players.
Source: "Pioneer, DuPont to Collaborate"
AgBiotech Reporter, September 1997.
|
Enter the gene splicers
Tomato both a multi-billion end product and the
raw material for a multi-billion industry was, from the very beginning,
an object of desire for the pioneer biotech companies and giant agrochemical
corporations, ready to grasp the potential markets offered by the new
technology and its associated property rights. So it is no surprise that
the first genetically modified crop to reach the market was Calgene's
transgenic Flavr Savr tomato. Nor that one of the first important
patent litigation battles was fought over a tomato gene.
Biotechnology R&D on tomato has roughly the same
objectives as conventional breeding _ resistance and quality. Needless
to say, the means to reach these goals have dramatically changed. The
main source of information on what is the trend in R&D may be found
in the patents.
According to "Derwent Biotechnology Abstracts",
up to June 1997 there were 153 patent or patent applications explicitly
claiming property on transgenic tomato plants. Since some patents refer
to more than one acquired trait (e.g. a transgenic tomato plant with longer
shelf-life and solids content), the addition of the number of altered
characteristics claimed is higher than the total number of patents. (See
Table
3)
Close to half of the claims on traits are related to
the agronomic characteristics of the crop, with viral resistance being
the top priority. Here Monsanto and Pioneer Hi-Bred are leading players.
Most of the these patents involve the insertion of a viral gene. This
is particularly worrying since new scientific evidence indicates that
re-combination between different viruses within a plant genome is an indisputable
fact. As for insect and nematode resistance, one quarter of the claims
are related to the use of Bacillus thuringiensis (Bt) proteins.
Pioneer Hi-Bred is the leader in research on insect resistance. Disease
resistance contains both bacterium-resistant and general disease-resistant
genetically-engineered plants. Unlike maize and soya, development
of herbicide tolerance has not appeared as a priority for the industry,
with only Monsanto and Du-Pont devoting special efforts to develop such
technology in tomato.
"Quality" remains high on the agenda
with two main objectives. Firstly to continue the quest for the long-shelf
life tomato, and also to design tomatoes with a higher solid content.
Genetic engineering is focusing on two approaches to
obtain the long-shelf life tomato, that is, a tomato that takes a long
time to get softer and thus unattractive for consumers. The first approach
is to delay the whole ripening process, by means of delaying the synthesis
of the main hormone that unleashes the ripening process, ethylene. This
approach has been undertaken mainly by ELM, Zeneca and Monsanto.
Another approach has been to delay one part of the process
stimulated by the ethylene, specifically the degradation of the cell walls
of the fruit, which results in its softening. With the ethylene production
unaltered, the rest of the process inherent in ripening continues in principle,
unaffected. So while the consumer may think that she/he is consuming a
fresh tomato, in fact only the most visible of the processes involved
in ripening _ softening has been delayed, the rest continue unchecked.
Hence the nutritious contents of a seemingly fresh tomato have
little to do with consumer expectations. Calgene's Flavr Savr, withdrawn
from the market in 1996, is the most notable example of this approach.
However giants such as Zeneca, Unilever and Monsanto continue to develop
and market the controversial technology.
The solids content of tomatoes is of high importance
for the processing industry as it has been estimated that an increase
of the solids content of tomatoes from 5 to 6% would save the tomato industry
about US$75 million in the US alone. Zeneca and Monsanto are again the
leaders in this field. The industry has further staked an interest in
using transgenic tomatoes to develop vaccines and human proteins.
| WAR AND PEACE
The US patent application for non-softening
tomato technology filed by ICI (later Zeneca) in 1986, made
public the company's lucrative trade secret. The profit potential
of the technology soon had corporate muscles flexing such that
in 1989 Calgene contested Zeneca's patent application arguing
they were manipulating the same gene. Calgene had developed
its technology in partnership with Campbell Soup, who held exclusive
world-wide rights on commercialisation of transgenic tomatoes.
After litigation, in February 1994, the three
companies decided to settle their conflict regardless of what
the Patent Office decided. In the agreed deal Campbell Soup
sold its exclusive rights to the use of the polygalacturonase
gene to Calgene and Zeneca. Calgene was to hold exclusive world-wide
rights in fresh tomatoes, while processed tomatoes were to be
shared between Campbell and Zeneca, which hold the right to
sub-license the technology to other processors.
The battle didn't stop there as in 1995 Calgene
was attacked by Enzo Biochem who claimed that the technology
Calgene was using to genetically alter its Flavr Savr
tomato was based on fraudulent research. Enzo holds a patent
covering the use of antisense technology, which Calgene uses
in its Flavr Savr. However Enzo lost its infringement
suit as the court ruled that Enzo's three patents covering the
technology were invalid, because the disclosures in the patents
did not enable others to practice the claimed invention, and
confirmed the validity of Calgene's patent. Of course, Enzo
appealed the decision and in the meanwhile has lobbied support
from both the European and Japanese patent offices.
|
Patent options
A patent issued on a technology and its products does
not automatically mean that the technology will be developed by the holder.
Patents provide control on potential future development options. The reasoning
for obtaining patents is that those owning a large number of them will
be able to grasp the most benefits on future markets. So, who is positioning
itself to control the tomato market? The top 6 patent applicants control
49% of the patents. Not surprisingly, the list includes the agrochemical
giants that are in control of plant genetic engineering . The control
of agronomic properties in tomato is divided between Pioneer and Monsanto.
On product quality, Zeneca and Monsanto appear as the dominant actors,
with the exception of niche areas, such as the alteration of protein content,
or the use of tomato as a source of human proteins.
In their bid for patents corporate clients continue to
strengthen ties with public research. The importance of public research
centres in the area of tomato R&D and patents is particularly high.
At least 32 of the 153 patents analysed (21%) have a public institution
as one of the patent applicants. The University of California alone accounts
for 10 patents, though is the sole patent applicant for 7 of them. The
rational behind public centres applying for patents is to gain sources
of financing which allow them to maintain their independent research.
Independent to what point, if it is to serve a corporate clientele?
Transgenic tomatoes in the field
A look at what is being tested in the field highlights
which of the research lines are considered to have economic potential.
New Genetically Manipulated Organisms (GMOs) have to be tested in the
field in order to discover whether the chosen characteristics are expressed
in a way which is suitable for their developers. Most OECD countries now
have regulations on the release of GMOs into the environment, and many
keep track of field tests. The US keeps similar records in a database
which is updated daily and accessible through the Internet. As the US
is one of the largest markets for tomatoes, the field tests conducted
there are highly representative of what the industry is up to.
Table
3. Characteristics claimed in 153 patents granted
on transgenic tomato plants.
| AGRONOMIC CHARACTERISTICS |
CLAIMED |
% |
| Viral resistance |
28
|
17
|
| Fungal resistance |
16
|
10
|
| Insect resistance |
15
|
9
|
| Disease resistance |
11
|
7
|
| Nematode resistance |
5
|
3
|
| Herbicide tolerance |
3
|
2
|
| PRODUCT QUALITY |
|
|
| Long shelf-life |
31
|
19
|
| Altered solids content |
11
|
7
|
| Altered content |
15
|
9
|
| OTHERS |
|
|
| Technology improvements |
12
|
7
|
| Others |
16
|
10
|
| TOTAL CLAIMS ON TRAITS |
163
|
100
|
Source: GRAIN, from Derwent Biotechnology Abstracts.
To date there have been 510 field tests involving transgenic
tomato, accounting for 12% of all the field tests on transgenic organisms
either allowed or notified. A look at what characteristics have been tested
highlights that virus resistance has been the most widely tested agronomic
characteristic. 57% of tests on viral-resistant tomatoes have been conducted
by companies now owned by Monsanto. Both Upjohn and ELM (owner of: Seminis,
DNAP, Asgrow Seeds and PetoSeed) follow in second place.
At least 23 of the 48 releases to test insect resistance
involve the Bt protein. In the other 17 cases there is no information
available of the origin of the gene, as it is considered "Commercial
Business Information" (CBI). In both cases, Monsanto is by far
the highest tester, which suggests that they may involve Bt. These research
trends show that in spite of the wide spectrum of potential technologies
it is in reality quite narrow.
Battle lines and back-room deals
The battle of corporate control on tomato is being fought
between three giants, Monsanto, Empresas la Moderna (ELM) and Zeneca.
Having specialised in the niche market of insect resistance, Pioneer appears
content to be out of the running. Although the three have also developed
transgenic tomato with new agronomic properties, it has been the possibility
to alter the properties of the tomato that look likely to hold the key
for future market control. Time will tell whether the weaker patent portfolio
of ELM effects its bid for supremacy.
Table 4. Patent applications on transgenic
tomato plants up to June 97: Top 6 patent holders account for 51% of the
patents.
| COMPANY |
PATENTS |
% |
| Monsanto |
22
|
14
|
| Zeneca |
19
|
12
|
| Pioneer-Hi-Bred-Intl. |
13
|
8
|
| University California |
10
|
7
|
| Empresas La Moderna |
6
|
4
|
| Novartis |
5
|
3
|
| OTHERS |
78
|
51
|
Source: GRAIN, from Derwent Biotechnology Abstracts
The showdown between the three may have seen some tough
posturing, but back-room deals being struck show a surprising level of
co-operation. In February 97, DNA Plant technologies (DNAP) announced
a technology collaboration agreement between its owner ELM and Monsanto
which permitted DNAP to use Monsanto's genetic engineering technology
for fruit and vegetables. Zeneca on the other hand, has developed a tomato
with ELM's PetoSeed.
While fierce market competition may be assigning territory,
we are already seeing companies shaking hands over the fence in recognition
of their areas of market dominance. The double dealing and back stabbing
is bound to continue when it suits corporate strategy, but all recognise
that alliances can sometimes be profitable.
Control of global desires
From its mountain top existence, the humble tomato has
been catapulted to a position of global fame and desire. All icons have
their managers and tomato is no exception - as the insatiable demand has
grown so too have breeder's efforts to meet it and keep it moving. The
global hype has inevitably led to an unsustainable situation with industrial
intensification leading to alarming genetic uniformity among varieties.
With a global demand secured, the next step is to take
control of the supply. Centralised production, large scale distribution
and industrial processing are at the core of current research on tomato.
Other qualities such as flavour and nutritional content take a back seat.
As with other crops, industry giants have turned to gene technology with
its patent protection, as the preferred method of control. With biotechnology,
tomatoes are produced further away, in a rigid chain of production where
a single company like Calgene, may control the entire process from plant
to dish.
The bold claims of gene technologists ring hollow. As
the latest expression of industrial agriculture, biotech merely extends
and deepens the crisis of genetic erosion and local food security. Lofty
claims of tomato improvements are in any case ultimately dependent not
on isolating genes but on the wild tomato and varieties developed by farmers
over centuries.
Sources:
* Beck, P. (1995) "The Heirlooms - Tomatoes with
Roots in the Past", The Seed Savers, Summer Edition, pp. 123-126.
* Chrispels, M., D.E. Sadava (1994) Plants, Genes
and Agriculture, Jones and Barlett Publishers International, London.
P. 411.
* Edwards, C.A. et al. (Ed) (1990) Sustainable
Agricultural Systems Soil and Water Conservation Society. Stl.
* Lucie Press, Florida.
* Fowler, C. and P. Mooney, (1990) Shattering: Food,
Politics, and The Loss of Genetic Diversity, University of Arizona
Press.
* Genetics Forum (1996) "New Tomatoes For Old?"
The Splice of Life, March 1996, p. 1-2.
* Genetics Forum (1996) "High-tech tomato hits low-tech
problems" The Splice of Life, April 1996, p.3.
* Gry, L. (1994) "La tomate en révolution permanente",
Semences et Progrès, No 78, janvier-février-mars 94, pp. 20-34.
* Heijbroeck et al, (1996) The World seed market:
Developments and strategies, Rabobank, Utrecht, second revised edition,
p. 18.
* Kleiner, K. (1997) "Fields of genes", New
Scientist No2095, 16 August 1997, p. 4.
* Male, C. (1995) "Heirloom Tomatoes", The
Seed Savers, Summer Edition, pp. 127-130.
* Philouze, J. (1994) "Les tomates", Sauve
qui Peut!, No. 6-7 Décembre 1995, pp. 22-25
* Rick, C. M. (1978), "The tomato", Scientific
American, Vol. 239, pp. 75-87.
* TGRC Web page.
* AGROSTAT, FAO.
| EVIDENCE MOUNTS OF VIRUS RE-COMBINATION
The main approach to virus-resistance in genetic
engineering consists of inserting one or more genes coding for
a viral protein into the genome of a plant to make it resistant
to infection by the same virus. For many years, critics have
pointed out that this approach risks recombining these genes
with existing viruses resulting in new, potentially dangerous
strains. Advocates of the technology have always argued that
there was no evidence of such recombination, and even less of
the fact that the new viruses could be dangerous. Needless to
say, the USDA has traditionally adopted this position.
However, the growing weight of evidence could
lead to a change within regulations. A Canadian plant virologist
has shown recombination between two different kinds of viruses
within a plant for the first time. Dr. Ann Rochon infected plants
with a cucumber mosaic virus lacking the gene to make the protein
that allows it to move from cell to cell. She then took an equivalent
gene from another virus and inserted it into the plants. The
results showed fully functioning mosaic viruses in one in eight
of the plants.
This first evidence should at the very least
lead to an immediate moratorium on commercialisation of virus
resistant crops until a stronger risk assessment program is
introduced, as the Union Concerned Scientists already asked
for in 1993. The USDA has not yet reacted but industry, keen
to capitalise on expensive R&D investments, is unlikely
to let them go down the sink without resistance.
Source: "Fields of genes", New
Scientist, 16 August 1997, p. 4.
|
|